Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Clinical trial NCT06808984 · RECRUITING
Trial details
- NCT number
- NCT06808984
- Sponsor
- Celgene
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-09
- Primary completion
- 2027-11-26
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.